Financial Statements — GRRR
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 |
|---|
| Cash & Equivalents | 10.11 | 11.22 |
| Inventory | 0.01 | 0.02 |
| Total Current Assets | 125.42 | 94.74 |
| Total Non-current Assets | 37.32 | 38.37 |
| Total Assets | 162.75 | 133.11 |
| Total Current Liabilities | 58.05 | 54.94 |
| Total Non-current Liabilities | 6.51 | 6.12 |
| Total Liabilities | 64.57 | 61.06 |
| Retained Earnings | (156.74) | (81.79) |
| Total Stockholder Equity | 98.18 | 72.06 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 |
|---|
| Total Revenue | 39.33 | 20.67 |
| Cost of Revenue* | 25.88 | 3.00 |
| Gross Profit | 13.45 | 17.68 |
| Research & Development | 1.23 | 1.15 |
| Selling, General & Admin | 7.27 | 6.02 |
| Total Operating Expenses | 22.52 | 15.91 |
| Operating Income | (9.07) | 1.77 |
| Interest Expense | 0.29 | 0.42 |
| Pretax Income | (8.19) | 1.75 |
| Tax Provision | 0.32 | 0.14 |
| Net Income | (8.50) | 1.61 |
| Basic EPS | (0.43) | 0.17 |
| Diluted EPS | (0.43) | 0.15 |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 |
|---|
| Operating Cash Flow | (12.52) | (11.26) |
| Investing Cash Flow | (4.85) | (0.46) |
| Financing Cash Flow | 5.33 | 17.51 |
